Loxanast

This classification denotes an immunosuppressant with the molecular formula C14H26O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 746YWK1B07, chemically known as cyclohexanecarboxylic acid, 1-methyl-4-(4-methylpentyl)-, cis- but more generally known as loxanast, which bears US NIH Compound Identifier 68890. European Medicines Agency schedules Loxanast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08606MIG. The term LOXANAST is an International Non-Proprietary Name. LOXANAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule loxanast under HS 29162000 and SITC 51379. As of Q4 2014, LOXANAST remains US FDA's Preferred Term for this commodity. Loxanast bears US NLM identifiers UMLS ID C2825487 and NCI Concept Code C81164. SMILES: OC(=O)C1(CCC(CC1)CCCC(C)C)C.